Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
11.83
-0.51 (-4.13%)
At close: Mar 20, 2026, 4:00 PM EDT
11.70
-0.13 (-1.10%)
After-hours: Mar 20, 2026, 7:26 PM EDT

Amneal Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
127.93-73.88-48.72-254.7920.17
Depreciation & Amortization
223.57236.19229.4240.18233.41
Stock-Based Compensation
31.9527.7726.8231.8528.41
Other Adjustments
161.05109.08185.26107.8193.43
Change in Receivables
-120.57-162.64126.29-79.72-23.62
Changes in Inventories
-87.03-130.53-126.18-102.4-49.02
Changes in Other Operating Activities
3.08289.1-47.29122.17-60.96
Operating Cash Flow
339.99295.1345.5865.1241.82
Operating Cash Flow Growth
15.21%-14.61%430.84%-73.08%-36.20%
Capital Expenditures
-98.84-60.34-46.8-48.8-50.94
Sale of Property, Plant & Equipment
2.09----
Purchases of Intangible Assets
-15.51-14.65-22.39-41.8-1.7
Payments for Business Acquisitions
----84.71-146.54
Proceeds from Business Divestments
-11.99---
Other Investing Activities
---15
Investing Cash Flow
-112.26-63-69.19-174.31-194.18
Short-Term Debt Issued
2184821985-
Net Short-Term Debt Issued (Repaid)
2184821985-
Long-Term Debt Issued
2,695-217.73--
Long-Term Debt Repaid
-2,812-188.92-414.08-123.27-78.09
Net Long-Term Debt Issued (Repaid)
-116.76-188.92-196.35-123.27-78.09
Issuance of Common Stock
1.961.150.450.660.85
Repurchase of Common Stock
-22.28-7.95-2.38-3.57-2.66
Net Common Stock Issued (Repurchased)
-20.32-6.8-1.93-2.91-1.81
Other Financing Activities
-112.45-64.08-233.3-65.44-58.23
Financing Cash Flow
-31.53-211.79-212.57-106.62-138.12
Effect of Exchange Rate Changes on Cash and Cash Equivalents
-1.68-10.07-5.680.1
Net Cash Flow
194.5219.3163.88-221.51-90.38
Free Cash Flow
241.15234.76298.7816.31190.88
Free Cash Flow Growth
2.72%-21.43%1732.42%-91.46%-39.82%
FCF Margin
7.99%8.40%12.48%0.74%9.12%
Free Cash Flow Per Share
0.740.761.70--
Levered Free Cash Flow
214.0876.62-52.2242.895.03
Unlevered Free Cash Flow
402.95669.24256.39113.68170.7
Updated Feb 27, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q